Calcipotriol - Polichem

Drug Profile

Calcipotriol - Polichem

Alternative Names: P 3073

Latest Information Update: 19 Apr 2017

Price : $50

At a glance

  • Originator Polichem
  • Class Antipsoriatics; Cyclohexanes; Dihydroxycholecalciferols; Indenes; Vitamin D analogues
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Psoriasis

Most Recent Events

  • 28 Mar 2017 Polichem plans a phase III trial for Psoriasis in USA (NCT03079973)
  • 08 Feb 2017 Polichem completes a phase III trial in Psoriasis in Bulgaria, Czech Republic, Germany, Greece, Latvia, Poland and Russia (Topical) (EudraCT2015-002365-34)
  • 29 Apr 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top